Coverage of Conditions and Treatments (Coverage Decisions)
Use this lookup tool to determine coverage decisions, or if prior authorization is needed for the treatment or condition. Note: For Self-insured employer claims, you must contact the employer or their claims administrator.
List also available in PDF format.
See Treatment Guidelines and Resources for additional information.
The NeuMed Brevio® nerve conduction testing system is a handheld device intended for use in evaluating nerve function.
Coverage decision
The Brevio® Nerve Conduction Testing System is not covered at this time. L&I reviewed the scientific literature and determined there is not sufficient evidence of efficacy for this diagnostic tool. Brevio® is considered investigational and experimental.
This coverage decision applies to all State Fund and self-insured claims in all locations.
Background information
The NeuMed Brevio is a handheld device intended for use in evaluating nerve function. Similar to conventional nerve conduction study devices, the Brevio® assesses function via surface electrodes. This evidence does not support the accuracy or reliability of Nervepace for use as a diagnostic or screening tool for any condition(s) and specifically for carpal tunnel syndrome.
Billing information
Nerve conduction tests performed with Brevio® do not have unique billing codes at this time. The manufacturer of Brevio® recommends use of CPT codes:
- 95900,
- 95903,
- 95904.
These codes apply to billing for motor nerve testing, motor nerve testing with F-waves and sensory nerve testing.
Note: These codes are approved only for nerve conduction studies performed with traditional nerve conduction testing systems.
In accordance with WAC 296-20-03002, L&I will not pay for treatment which is considered experimental in nature. L&I may recoup payments plus interest for nerve conduction tests paid inappropriately.